CODY JACKSON: Open Payments
NPI 1770715146 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 89 payments from 16 companies in 2025. Trend: 2023 $1,451 · 2024 $1,976 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 34 | $568 |
| Daiichi Sankyo Inc. | 20 | $289 |
| ViiV Healthcare Company | 4 | $197 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $145 |
| Novo Nordisk Inc | 5 | $111 |
| SANOFI-AVENTIS U.S. LLC | 3 | $77 |
| Exact Sciences Corporation | 2 | $50 |
| Boston Scientific Corporation | 1 | $47 |
| Philips North America LLC | 1 | $39 |
| Lilly USA, LLC | 1 | $27 |
Products named: INJECTAFER, APRETUDE, XIFAXAN, Wegovy, TZIELD, Biktarvy, Cologuard Collection Kit, WaveWriter Alpha Prime 16.
Industry payments across CA — which companies pay providers there.
